This is the best advice I have read about the Coronavirus.

New Post Public Reply Private Reply Replies (1) Message Board
toodles
217
This is the best advice I have read about the Coronavirus. And the most sensible.
GREAT COVID-19 INFO!!

From a local nurse: ( unknown source)

“So what I have seen a lot of is recommendations for how to try to avoid getting coronavirus in the first place -- good handwashing -- but what I have NOT seen a lot of is advice for what happens if you actually get it, which many of us will. So as your friendly neighborhood RN, let me make some suggestions.
You basically just want to prepare as though you know you’re going to get a nasty respiratory bug, like bronchitis or pneumonia. You just have the foresight to know it’s coming.
Things you should actually buy ahead of time (not sure what the obsession with toilet paper is?): Kleenex, Acetaminophen (Tylenol) in 325 mg tablets, Ibuprofen (Advil) in 200 mg tablets, Mucinex, Robitussin or whatever your generic cough medicine of choice is (check the label and make sure you're not doubling up on acetaminophen - some brands like DayQuil have it included and you don't want that). You want a cough medicine with both a cough suppressant and expectorant. Vix vaporub for your chest is also a great suggestion. (Also I should think this would go without saying, but editing to add that of COURSE if you have a medical contraindication to any of these over the counter meds, you should not take them. Check with your doc or pharmacist if you’re even the slightest bit unsure and these aren’t meds you routinely take for a cough/cold)
If you don’t have a humidifier, that would be a good thing to buy and run in your room when you go to bed overnight. (You can also just turn the shower on hot and sit in the bathroom breathing in the steam). If you have a history of asthma and you have a prescription inhaler, make sure the one you have isn’t expired and refill it/get a new one if it is.
This is also a good time to meal prep: make a big batch of your favorite soup to freeze and have on hand. Whatever your favorite clear fluids are to drink (Sprite, juice, ICE waters, Fresca, whatever floats your boat), stock your pantry with those. Maybe get some nice soothing tea too!
For symptom management, use the meds I mentioned. For a fever over 101, alternate Tylenol 650 mg and Advil 400 mg so you’re taking a dose of one then the other every 3 hours.
Drink A TON, hydrate hydrate hydrate. Rest lots. You should not be leaving your house except to go to the doctor, and if you do, wear a mask (regular is fine, you don’t need an N95).
You DO NOT NEED TO GO TO THE ER unless you are having trouble breathing or your fever is very high and unmanaged with meds. 90% of healthy adult cases thus far have been managed at home with basic rest/hydration/over-the-counter meds. We don’t want to clog the ERs unless you’re actually in distress. The hospital beds will be used for people who actively need oxygen/breathing treatments/IV fluids.
If you have a pre-existing lung condition (COPD, emphysema, lung cancer) or are on immunosuppressants, now is a great time to talk to your PCP or specialist about what they would like you to do if you get sick. They might have plans to get you admitted and bypass the ER entirely.
One major relief to you parents is that kids do VERY well with coronavirus— they usually bounce back in a few days, NO ONE under 18 has died, and almost no kids have required hospitalization (unless they have a lung disease like CF). Be sure to use kids formulations of OTC meds and dose appropriately for their age/weight, and ask the pediatrician if you have any questions about medication safety for your child’s age.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Plata Hits $1 Billion ARR in Record Digital Bank Growth

Updated Category News Views 14

Plata Rocks the Boat with Rapid Revenue Growth When a digital bank like Plata rakes in $1 billion in Annual Recurring Revenue (ARR) within just 3.5 years, you can't just shrug it off. That's blazing fast by any standard, especially for a financial institution. Emerging from Mexico, this bank's rocket-like ascent is flinging the doors wide open for what's possible in the...

Continue Reading
Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 8

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 5

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
Steel Dynamics' Q3 2026: Record Shipments Boost Profits

Updated Category News Views 5

Steel Dynamics Shatters Records in Q3 2026 If there was any doubt about Steel Dynamics' ability to ride the waves in the steel and aluminum market, the third quarter of 2026 put that to rest. With a record-breaking 3.8 million tons of steel shipped and net sales reaching a steep $6.5 billion, this isn't just business as usual—it's smashing their own ceiling. Operating...

Continue Reading
Zika Virus: A Surprising Ally in Brain Cancer Fight

Updated Category News Views 8

Here’s something you don’t hear every day: using a virus that typically targets the brain not as a foe, but as a formidable ally in the war against glioblastoma. It’s a gutsy play by UP Oncolytics, a scrappy biotech outfit cradled within Rosalind Franklin University’s Helix 51 incubator. Risky Bet on a Known Adversary Glioblastoma—a real beast in the cancer...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 8

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
Chemours Faces Investor Fraud Suit: Action Needed Now

Updated Category News Views 10

A Messy Situation Unfolds for Chemours Company You know, stumbling upon a battle scene like this isn't something I enjoy, but here we have Chemours Company (NYSE: CC) embroiled in a securities fraud lawsuit. It's like catching wind of a brawl outside your favorite tavern—can't ignore it, can you? The Lawsuit's Crux and Key Dates to Watch Here's the rundown. The fight...

Continue Reading
Firmable's Tech Intelligence: New Edge in B2B Sales

Updated Category News Views 14

New Era for B2B Sales Teams Once again, the B2B sales landscape is getting a jolt—especially for those who’ve been fumbling in the dark pitching to prospects without any real idea of their tech environment. With the introduction of Firmable's Tech Intelligence, those blind days just got a lot brighter. By offering detailed insights into what technologies a company is...

Continue Reading
2GenPen & LordCap Team Up: Game-Changer in ABS?

Updated Category News Views 10

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Continue Reading
QFIN Faces Class Action: Investors' Role Explored

Updated Category News Views 8

Cracks in the Facade: QFIN's Legal Mess You're cruising down the usual market lanes when—bam!—news breaks that Qfin Holdings, Inc. (NASDAQ: QFIN) finds itself hip-deep in a class action lawsuit. Seems like our pals at Schall, Brown & Schwartz LLP have thrown the gauntlet down, with claims of some serious smoke and mirrors during the March to August stretch of 2026....

Continue Reading

Top 5 Most Recently Viewed Articles

Gold Mining Boom: A New Era of Growth and Innovation

Updated Category News Views 190

Introduction to Gold Mining Growth In recent years, the demand for gold has surged significantly, which in turn has fueled substantial growth in gold mining operations across North America. With various industries utilizing gold for its unique properties, these developments signal a new chapter for the gold mining sector. Market Growth Projections According to recent...

Continue Reading
Federal Spending Surges amidst Efficiency Initiatives

Updated Category News Views 209

Record Federal Spending Amid Efforts for Efficiency The U.S. federal spending reached a staggering $603.4 billion last month, even as initiatives aimed at streamlining operations are underway, led by influential figures in the business sector. The Current Spending Snapshot Recent statistics highlight a dramatic spike in spending, which has surged by $36 billion compared...

Continue Reading
Insulet's Initiatives for Diabetes Awareness Month and Beyond

Updated Category News Views 90

Insulet Corporation's Commitment to Diabetes Awareness Insulet Corporation (NASDAQ: PODD), recognized as a leader in tubeless insulin pump technology, is gearing up for an impactful November as it observes National Diabetes Awareness Month and World Diabetes Day. The company has exciting plans to engage communities and individuals in understanding diabetes and its...

Continue Reading
Exploring the Future of Aircraft Tire Markets Through 2035

Updated Category News Views 143

Growth Prospects of the Aircraft Tire Market The aircraft tire market is projected for significant growth from 2025 to 2035, anticipated to expand from USD 2,030.1 million to USD 3,704.8 million. This translates to a compound annual growth rate (CAGR) of 6.2%. The driving forces behind this increase include the ongoing expansion of commercial aviation, rising global air...

Continue Reading
DuPont and Habitat for Humanity: A Lasting Partnership

Updated Category News Views 142

DuPont Renews Global Partnership with Habitat for Humanity DuPont and Habitat for Humanity International are excited to announce the continuation of their impactful collaboration. With this renewed annual partnership, DuPont will be donating products, as well as providing essential cash contributions to support Habitat for Humanity's valuable projects worldwide....

Continue Reading